Edward Nash
Stock Analyst at Canaccord Genuity
(1.33)
# 1776
Out of 5,218 analysts
96
Total ratings
38.30%
Success rate
12.80%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Apogee Therapeutics | Initiates Coverage On: Buy | 89 | 44.27 | 101.04% | 1 | Nov 25, 2024 | |
Verona Pharma | Maintains: Strong Buy | 37 44 | 41.41 | 6.25% | 8 | Nov 5, 2024 | |
Travere Therapeutics | Maintains: Buy | 23 22 | 17.3 | 27.17% | 8 | Sep 30, 2024 | |
Ventyx Biosciences | Maintains: Buy | 15 14 | 2.27 | 516.74% | 6 | Aug 12, 2024 | |
Corcept Therapeutics | Maintains: Strong Buy | 38 78 | 55.4 | 40.79% | 5 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | 1.33 | 501.5% | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 59 56 | 28.86 | 94.04% | 5 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 20 | 2.42 | 726.45% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 9 | 1.65 | 445.45% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 338 377 | 302.46 | 24.64% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 66 | n/a | n/a | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 19 | n/a | n/a | 9 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 8 | 1.48 | 440.54% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 71 48 | n/a | n/a | 3 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 17 | 4.59 | 270.37% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 48 | 13.2 | 263.64% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 2 | 2.48 | -19.35% | 4 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 17 | n/a | n/a | 2 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 900 180 | 2.9 | 6106.9% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 52 | n/a | n/a | 2 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | n/a | n/a | 1 | Apr 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 1 | n/a | n/a | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 82 | 45.88 | 78.73% | 5 | Jun 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 120 80 | 5.38 | 1386.99% | 3 | Sep 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 3 | n/a | n/a | 1 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Oct 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 48 | 15.35 | 212.7% | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 650 | 5.87 | 10973.25% | 1 | Nov 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 0 | n/a | n/a | 3 | Sep 22, 2017 |